Drug interactions for the following drug(s)
Applies to: Depakote 500 MG Delayed Release Oral Tablet <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
The risk or severity of adverse effects can be increased when Valproic acid is combined with Bupropion.
Applies to: Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet <> Flomax 0.4 MG Oral Capsule
The metabolism of Tamsulosin can be decreased when combined with Bupropion.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Depakote 500 MG Delayed Release Oral Tablet <> Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 1099871, name = divalproex sodium 500 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug2 (rxcui = 993564, name = 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin], tty = SBD). Drug1 is resolved to valproic acid, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Valproic acid and Bupropion. Drug1 is resolved to valproate, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Valproic acid and Bupropion.
Applies to: Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet <> Flomax 0.4 MG Oral Capsule
Drug1 (rxcui = 993564, name = 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin], tty = SBD). Drug2 (rxcui = 863671, name = tamsulosin hydrochloride 0.4 MG Oral Capsule [Flomax], tty = SBD). Drug1 is resolved to bupropion, Drug2 is resolved to tamsulosin and interaction asserted in DrugBank between Bupropion and Tamsulosin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.